Global Blood Therapeutics Inc.
GBT
|
|
| |
|
| Trading Volume | 2,524,250 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 4.6B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | - | 18.4% |
| Q2 | - | - | - | -7.8% |
| Q3 | - | - | - | 111.9% |
| Q4 | - | - | - | - |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -3.2 | 6.6 | 14.7 | -11.4 | -17.6 | 26.2 | -0.1 | 112.7 | -0.3 | - | - | - |
| 2021 | |||||||||||
| 15.7 | -15 | -4.3 | 3.4 | -8.8 | -8.9 | -22 | 5 | -11.2 | 43.3 | -22.6 | 3.6 |
| 2020 | |||||||||||
| -19.1 | -6.2 | -16.1 | 49.8 | -8.6 | -9.7 | 6.9 | -5.8 | -13.3 | -4.1 | -15.9 | -2.6 |
EPS
| 2021 | 2020 | |
|---|---|---|
| Q1 | -1.2 | -1.2 |
| Q2 | -1.1 | -0.9 |
| Q3 | -1.1 | -1 |
| Q4 | 0 | -1 |
| A | -3.5 | -4 |